328 related articles for article (PubMed ID: 30016231)
1. In vitro activity of β-lactams in combination with avibactam against multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Achromobacter xylosoxidans isolates from patients with cystic fibrosis.
Mathy V; Grohs P; Compain F
J Med Microbiol; 2018 Sep; 67(9):1217-1220. PubMed ID: 30016231
[TBL] [Abstract][Full Text] [Related]
2. Trends in ceftazidime-avibactam activity against multidrug-resistant organisms recovered from respiratory samples of cystic fibrosis patients.
Farfour E; Trochu E; Devin C; Cardot Martin E; Limousin L; Roux A; Picard C; Jolly E; Vasse M; Lesprit P
Transpl Infect Dis; 2018 Oct; 20(5):e12955. PubMed ID: 29896802
[No Abstract] [Full Text] [Related]
3. Comparative activity of antimicrobials against
Spierer O; Miller D; O'Brien TP
Br J Ophthalmol; 2018 May; 102(5):708-712. PubMed ID: 29459431
[TBL] [Abstract][Full Text] [Related]
4.
Grohs P; Taieb G; Morand P; Kaibi I; Podglajen I; Lavollay M; Mainardi JL; Compain F
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096165
[TBL] [Abstract][Full Text] [Related]
5. In vitro antimicrobial activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and other non-fermenting Gram-negative bacteria in adults with cystic fibrosis.
Gramegna A; Millar BC; Blasi F; Elborn JS; Downey DG; Moore JE
J Glob Antimicrob Resist; 2018 Sep; 14():224-227. PubMed ID: 29559421
[TBL] [Abstract][Full Text] [Related]
6. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
Lobo LJ; Tulu Z; Aris RM; Noone PG
Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan.
Hsueh SC; Lee YJ; Huang YT; Liao CH; Tsuji M; Hsueh PR
J Antimicrob Chemother; 2019 Feb; 74(2):380-386. PubMed ID: 30357343
[TBL] [Abstract][Full Text] [Related]
8. Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis.
Saiman L; Chen Y; Gabriel PS; Knirsch C
Antimicrob Agents Chemother; 2002 Apr; 46(4):1105-7. PubMed ID: 11897598
[TBL] [Abstract][Full Text] [Related]
9.
Caverly LJ; Spilker T; Kalikin LM; Stillwell T; Young C; Huang DB; LiPuma JJ
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611364
[TBL] [Abstract][Full Text] [Related]
10. Avibactam Restores the Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia to Aztreonam.
Mojica MF; Papp-Wallace KM; Taracila MA; Barnes MD; Rutter JD; Jacobs MR; LiPuma JJ; Walsh TJ; Vila AJ; Bonomo RA
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784669
[No Abstract] [Full Text] [Related]
11. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
[TBL] [Abstract][Full Text] [Related]
12. Activity of Cefiderocol and Comparators against Isolates from Cancer Patients.
Rolston KVI; Gerges B; Shelburne S; Aitken SL; Raad I; Prince RA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071053
[TBL] [Abstract][Full Text] [Related]
13. Activity of Aztreonam in Combination with Avibactam, Clavulanate, Relebactam, and Vaborbactam against Multidrug-Resistant Stenotrophomonas maltophilia.
Biagi M; Lamm D; Meyer K; Vialichka A; Jurkovic M; Patel S; Mendes RE; Bulman ZP; Wenzler E
Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32928733
[TBL] [Abstract][Full Text] [Related]
14. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients.
Nazik H; Ongen B; Erturan Z; Salcioğlu M
Jpn J Infect Dis; 2007 May; 60(2-3):82-6. PubMed ID: 17515637
[TBL] [Abstract][Full Text] [Related]
15. Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients.
Chalhoub H; Tunney M; Elborn JS; Vergison A; Denis O; Plésiat P; Kahl BC; Van Bambeke F; Tulkens PM
J Antimicrob Chemother; 2015 May; 70(5):1596-8. PubMed ID: 25587996
[No Abstract] [Full Text] [Related]
16. In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates.
Testa R; Cantón R; Giani T; Morosini MI; Nichols WW; Seifert H; Stefanik D; Rossolini GM; Nordmann P
Int J Antimicrob Agents; 2015 Jun; 45(6):641-6. PubMed ID: 25748553
[TBL] [Abstract][Full Text] [Related]
17. [Use of 16S rRNA gene sequencing for identification of "Pseudomonas-like" isolates from sputum of patients with cystic fibrosis].
Moissenet D; Bingen E; Arlet G; Vu-Thien H
Pathol Biol (Paris); 2005; 53(8-9):500-2. PubMed ID: 16081224
[TBL] [Abstract][Full Text] [Related]
18. Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management.
Parkins MD; Elborn JS
J Antimicrob Chemother; 2010 Sep; 65(9):1853-61. PubMed ID: 20605846
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of colistin susceptibility in multidrug-resistant clinical isolates from cystic fibrosis, France.
Biswas S; Dubus JC; Reynaud-Gaubert M; Stremler N; Rolain JM
Eur J Clin Microbiol Infect Dis; 2013 Nov; 32(11):1461-4. PubMed ID: 23719852
[TBL] [Abstract][Full Text] [Related]
20. Rapid genotyping of Achromobacter xylosoxidans, Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolates using melting curve analysis of RAPD-generated DNA fragments (McRAPD).
Deschaght P; Van Simaey L; Decat E; Van Mechelen E; Brisse S; Vaneechoutte M
Res Microbiol; 2011 May; 162(4):386-92. PubMed ID: 21320595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
